Xavier Mariette

52.3k total citations · 8 hit papers
452 papers, 19.6k citations indexed

About

Xavier Mariette is a scholar working on Rheumatology, Physiology and Immunology. According to data from OpenAlex, Xavier Mariette has authored 452 papers receiving a total of 19.6k indexed citations (citations by other indexed papers that have themselves been cited), including 217 papers in Rheumatology, 126 papers in Physiology and 99 papers in Immunology. Recurrent topics in Xavier Mariette's work include Rheumatoid Arthritis Research and Therapies (151 papers), Salivary Gland Disorders and Functions (126 papers) and Systemic Lupus Erythematosus Research (112 papers). Xavier Mariette is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (151 papers), Salivary Gland Disorders and Functions (126 papers) and Systemic Lupus Erythematosus Research (112 papers). Xavier Mariette collaborates with scholars based in France, United States and United Kingdom. Xavier Mariette's co-authors include Gaëtane Nocturne, Raphaèle Séror, Lindsey A. Criswell, Jacques‐Eric Gottenberg, Manuel Ramos‐Casals, Philippe Ravaud, Corinne Miceli‐Richard, Simon Bowman, Hendrika Bootsma and Athanasios G. Tzioufas and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Xavier Mariette

425 papers receiving 19.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune-related adverse events of checkpoint inhibitors

2020 931 citations Olivier Lambotte, Xavier Mariette et al. profile →
EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

2009 656 citations Raphaèle Séror, Philippe Ravaud et al. Annals of the Rheumatic Diseases profile →
Primary Sjögren’s Syndrome

2018 582 citations Xavier Mariette et al. profile →
Sjögren syndrome

2016 546 citations Hendrika Bootsma, Simon Bowman et al. profile →
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

2017 302 citations Stanley Cohen, Yoshiya Tanaka et al. Annals of the Rheumatic Diseases profile →
FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

2014 285 citations Xavier Mariette, Jacques‐Eric Gottenberg et al. Annals of the Rheumatic Diseases profile →
B cells in the pathogenesis of primary Sjögren syndrome

2018 252 citations Gaëtane Nocturne, Xavier Mariette profile →
Systemic and organ-specific immune-related manifestations of COVID-19

2021 195 citations Xavier Mariette et al. profile →

Peers

Countries citing papers authored by Xavier Mariette

Since Specialization

Citations

This map shows the geographic impact of Xavier Mariette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Mariette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Mariette more than expected).

Fields of papers citing papers by Xavier Mariette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Mariette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Mariette. The network helps show where Xavier Mariette may publish in the future.

Co-authorship network of co-authors of Xavier Mariette

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Mariette. A scholar is included among the top collaborators of Xavier Mariette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Mariette. Xavier Mariette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren's disease 2024 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), Juliette Pascaud, (unknown), Élodie Rivière, (unknown), Lucilla Fabbri, Sophie Leboucher, (unknown), Cédric Messaoudi, (unknown), Alexandre David, Stéphan Vagner, Gaëtane Nocturne, Xavier Mariette, Rami Bechara	7
2	Characterisation of airway disease associated with Sjögren disease 2024 ·RMD Open ·(unknown), Marie‐Pierre Debray, Antoine Beurnier, (unknown), Pierre‐Antoine Juge, Robin Dhôte, C. Larroche, (unknown), E. Dernis, Olivier Vittecoq, Alain Saraux, Jacques‐Eric Gottenberg, É. Hachulla, Véronique Le Guern, Philippe Dieudé, Raphaèle Séror, Xavier Mariette, Gaëtane Nocturne	1
3	Clinical, biological, prognostic characteristics of patients with immune-mediated thrombotic thrombocytopenic purpura and Sjögren’s disease 2024 ·RMD Open ·(unknown), Laurent Gilardin, Gaëtane Nocturne, (unknown), Agnès Veyradier, Xavier Mariette, (unknown), (unknown), Bérangère S. Joly	0
4	Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study 2024 ·Arthritis & Rheumatology ·Thomas Dörner, Simon Bowman, Robert I. Fox, Xavier Mariette, Athena Papas, Thomas Grader‐Beck, Benjamin A. Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze‐Koops, Robert J. Moots, G. Junge, (unknown), Monika Sopala, Alexandre Avraméas, Wen‐Lin Luo, Wolfgang Hueber	3
5	Impact of patient ancestry on heterogeneity of Sjögren’s disease 2023 ·RMD Open ·Maxime Beydon, Raphaèle Séror, Véronique Le Guern, Pascale Chrétien, Xavier Mariette, Gaëtane Nocturne	6
6	Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome 2022 ·Annals of the Rheumatic Diseases ·Raphaèle Séror, Gabriel Baron, Marine Camus, Divi Cornec, Élodie Perrodeau, Simon Bowman, Stefano Bombardieri, Hendrika Bootsma, Jacques‐Eric Gottenberg, Benjamin A. Fisher, Wolfgang Hueber, J.A. van Roon, Valérie Devauchelle‐Pensec, P Gergely, Xavier Mariette, Raphaël Porcher, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	42
7	Renal involvement of lymphomas proven by kidney biopsy: report of 10 cases from a tertiary care center and comparison with the literature 2022 ·International Journal of Hematology ·(unknown), Sophie Ferlicot, L. Rocher, Florent L. Besson, (unknown), Jean‐Marie Michot, Thierry Lazure, Xavier Mariette, Gaëtane Nocturne, Olivier Lambotte, Mohamad Zaidan, Nicolas Noël	1
8	Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider 2021 ·Annals of the Rheumatic Diseases ·Alessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, (unknown), (unknown), Dennis McGonagle, Pedro Machado	26
9	Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine 2021 ·Rheumatology International ·(unknown), Dennis Lendrem, James Wason, Jessica Tarn, (unknown), Iris L. A. Bodewes, Marjan A. Versnel, Jacques‐Eric Gottenberg, Raphaèle Séror, Xavier Mariette, Wan‐Fai Ng	16
10	Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider 2021 ·RMD Open ·Aurélie Najm, Alessia Alunno, Xavier Mariette, Benjamin Terrier, Gabriele De Marco, (unknown), (unknown), Dennis McGonagle, Pedro Machado	13
11	Interleukin‐7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren’s Syndrome 2020 ·Arthritis & Rheumatology ·Élodie Rivière, Juliette Pascaud, (unknown), (unknown), Bineta Ly, Audrey Paoletti, Raphaèle Séror, Nicolas Tchitchek, Michaël Mingueneau, Nikaïa Smith, Darragh Duffy, Lydie Cassard, Nathalie Chaput, Sabrina Pengam, Vanessa Gauttier, Nicolas Poirier, Xavier Mariette, Gaëtane Nocturne	39
12	EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 2020 ·Annals of the Rheumatic Diseases ·Robert Landewé, Pedro Machado, Féline P B Kroon, Hans Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John D. Isaacs, Xavier Mariette, Iain B. McInnes, Ulf Müeller-Ladner, Peter Openshaw, Josef S Smolen, Tanja Stamm, Dieter Wiek, Hendrik Schulze‐Koops	153
13	Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme 2020 ·RMD Open ·Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash, Kevin Winthrop, Christina Charles‐Schoeman, Lisy Wang, Connie Chen, Kenneth Kwok, Pinaki Biswas, Andrea Shapiro, Ann Madsen, J. Wollenhaupt	135
14	Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study 2019 ·BMJ ·Jacques‐Eric Gottenberg, Jacques Morel, Élodie Perrodeau, Thomas Bardin, Bernard Combe, Maxime Dougados, René‐Marc Flipo, Alain Saraux, Thierry Schaeverbeke, Jean Sibilia, Martin Soubrier, Olivier Vittecoq, Gabriel Baron, Arnaud Constantin, Philippe Ravaud, Xavier Mariette	93
15	Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement 2019 ·RMD Open ·Salam Abbara, Raphaèle Séror, Julien Henry, Pascale Chrétien, Aude Gleizes, Salima Hacein‐Bey‐Abina, Xavier Mariette, Gaëtane Nocturne	21
16	Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study 2018 ·European Journal of Internal Medicine ·Maxime Samson, H. Devilliers, K.H. Ly, F. Maurier, Boris Bienvenu, Benjamin Terrier, Pierre Charles, Loı̈c Guillevin, J.-F. Besancenot, É. Liozon, A.L. Fauchais, Romaric Loffroy, Christine Binquet, Sylvain Audia, Raphaèle Séror, Xavier Mariette, Bernard Bonnotte	30
17	Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde 2018 ·Revue du Rhumatisme ·C. Daïen, C. Hua, C. Gaujoux-Viala, Alain Cantagrel, (unknown), Maxime Dougados, Bruno Fautrel, Xavier Mariette, (unknown), Christophe Richez, Alain Saraux, (unknown), Daniel Wendling, Laure Gossec, Bernard Combe	6
18	Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study 2016 ·Annals of the Rheumatic Diseases ·Paul Emery, Clifton O. Bingham, Gerd R Burmester, Vivian P. Bykerk, Daniel E. Furst, Xavier Mariette, Désirée van der Heijde, Ronald van Vollenhoven, Catherine Arendt, Irina Mountian, O. Purcaru, Daljit Tatla, Michael E. Weinblatt, (unknown)	72
19	Sjögren Syndrome‐associated lymphomas: an update on pathogenesis and management 2014 ·British Journal of Haematology ·Gaëtane Nocturne, Xavier Mariette	190
20	[Anti-cytokines in the treatment of inflammation]. 2003 ·PubMed ·Xavier Mariette	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact